In conclusion, our findings demonstrate that PM impairs skin barrier function in AD through HDAC3 and HDAC6-mediated suppression of FLG, and that this effect can be reversed by the pan-HDAC inhibitor TSA [21, 22, 25]. Here, HDAC3 is linked to Alzheimer disease.